39 results
10-K
2023 FY
MREO
Mereo Biopharma Group Plc
27 Mar 24
Annual report
5:20pm
may be delayed or impossible to recover;
we may be subject to litigation or product liability claims; and
our reputation may suffer.
Any … , liability claims may result in:
decreased demand for our product candidates;
injury to our reputation;
withdrawal of clinical trial participants;
costs
10-K
2023 FY
EX-19.1
MREO
Mereo Biopharma Group Plc
27 Mar 24
Annual report
5:20pm
so‑called insiders). We have all worked hard over the years to establish a reputation for integrity and ethical conduct, and we cannot afford to have … that reputation damaged.
This Policy addresses compliance with applicable U.S. laws. Many other laws, including without limitation the laws
S-8
EX-99.1
twn5758waf7hml3 xz
15 Jan 21
Registration of securities for employees
4:21pm
F-1/A
zt47 wzpjd
12 Mar 20
Registration statement (foreign) (amended)
5:15pm
F-1/A
0sq04s mzgz3
6 Mar 20
Registration statement (foreign) (amended)
5:32pm
S-8
EX-99.1
rtjhd 2d64d7h
18 Feb 20
Registration of securities for employees
5:17pm
S-8
EX-99.1
zjyqssozk8uhl wvvzp
21 May 19
Registration of securities for employees
1:53pm